Uterine Cervical Dysplasia
28
3
3
24
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 28 trials
100.0%
+13.5% vs benchmark
18%
5 trials in Phase 3/4
17%
4 of 24 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 24 completed trials
Clinical Trials (28)
Phase II Study of Dysplasix™ Intravaginal Suppositories in Patients With High-Risk HPV (Hr-HPV) and Either (1) ASC-US or (2) Low-Grade Squamous Intraepithelial Lesions (LSIL)
Comparison of Pelvic Lymphadenectomy Versus Isolated Sentinel Lymph Node Biopsy Procedure for Early Stages of Cervical Cancers : a Multicenter Study With Evaluation of Medico-economic Impacts
Developing a Combined Molecular Screening and Triage Test for Cervical Cancer in Self-samples
Effectiveness of HPV Vaccine in Thai Adult Women
Lugol's Solution in Addition to Acetic Acid During Colposcopy
LLETZ With Videocolposcopy Versus LLETZ With Binocular Colposcopy
Forced Versus Spray Coagulation in Women Undergoing LLETZ-conization for Cervical Dysplasia: a Randomized Trial
HIV Indicator Diseases in Hospital and Primary Care
Conservative Management of HSIL in Patients With Future Pregnancy Aspiration
LLETZ Under Direct Colposcopic Vision
The SAFE Study: Satisfaction and Adherence to Follow-Up With Colposcopy Exams
LLETZ Under General Versus Local Anesthesia
Impact of AV2 Antiviral Drug on the Treatment of HPV-associated Lesions of the Uterine Cervix
Music and Colposcopy in Women With Cervical Dysplasia.
Video Colposcopy in Women With Dysplasia
Fischer Cone Biopsy Excisor Versus Loop Excision Procedure for Conization
Clinical Trial for the Use of a Novel Cell Collector Device to Retrieve Cells From the Uterine Cervix
Hemostatic Procedure After Biopsy of the Cervix
Buffered Lidocaine for Loop Electrosurgical Excision Procedures (LEEPs)
Trial on Safety and Pharmacokinetics of Intravaginal Curcumin